Leukotriene B4-synthesizing enzyme (LTA4H) is involved in reducing breast tumor growth and improving chemotherapy in lipid sphingosine-1-phosphate receptor 4 (S1PR4) ablation manner and via CD8+ T-cell expansion (52). This evidence concerns the gene LTA4H and breast neoplasm.